Match each patient's clinical presentation with the specific host cell receptor targeted by the responsible viral pathogen.
- A 6-year-old girl presenting with a bright red macular rash on her cheeks followed by a lacy, reticular rash on her extremities.Erythrocyte P antigen (globoside)
- A 20-year-old college student presenting with severe fatigue, exudative pharyngitis, splenomegaly, and atypical lymphocytosis.CD21 (Complement receptor 2)
- A 35-year-old spelunker presenting with agitation, muscle spasms, and severe pharyngeal pain when attempting to drink water.Nicotinic acetylcholine receptor (nAChR)
- A 25-year-old teacher presenting with low-grade fever, rhinorrhea, and a scratchy throat resolving over 5 days.Intercellular adhesion molecule-1 (ICAM-1)
- A 65-year-old man presenting with acute hypoxemic respiratory failure, bilateral ground-glass opacities, and sudden anosmia.Angiotensin-converting enzyme 2 (ACE2)
Cevap
Parvovirus B19 matches with Erythrocyte P antigen; EBV matches with CD21; Rabies virus matches with nAChR; Rhinovirus matches with ICAM-1; and SARS-CoV-2 matches with ACE2.
Each vignette describes a distinct viral infection characterized by a highly specific host cellular receptor required for initial pathogenesis. Parvovirus B19 targets the P antigen on erythroid precursors; Epstein-Barr Virus targets CD21 on B cells; Rabies virus targets the nicotinic acetylcholine receptor at the neuromuscular junction; Rhinovirus targets ICAM-1 on respiratory epithelium; and SARS-CoV-2 targets ACE2 on pneumocytes.
Adım Adım Çözüm
Anahtar Kavram
Viral tropism and the resulting clinical pathogenesis are fundamentally determined by the ability of specific viral surface proteins to bind distinct host cell receptors.